Table 1 Clinical characteristics of the study cohort
|  | Total (n = 12,326) | Tertile of TyG index | |||
|---|---|---|---|---|---|
I (lowest) (n = 4117) 6.77–8.40 | II (n = 4129) 8.41–8.91 | III (highest) (n = 4080) 8.92–11.62 | P | ||
Age, years | 51.7 ± 8.5 | 51.4 ± 9.0 | 52.1 ± 8.4 | 51.6 ± 8.0 | < 0.001 |
Male, n (%) | 10,382 (84.2) | 2974 (72.2) | 3633 (88.0) | 3775 (92.5) | < 0.001 |
Systolic BP, mmHg | 119.6 ± 15.0 | 117.1 ± 15.0 | 119.8 ± 14.9 | 121.8 ± 14.8 | < 0.001 |
Diastolic BP, mmHg | 75.0 ± 10.5 | 72.9 ± 10.7 | 75.2 ± 10.2 | 77.1 ± 10.3 | < 0.001 |
BMI, kg/m2 | 24.6 ± 2.8 | 23.5 ± 2.7 | 24.6 ± 2.6 | 25.5 ± 2.6 | < 0.001 |
Hypertension, n (%) | 4016 (33.5) | 1036 (26.2) | 1355 (33.8) | 1625 (40.8) | < 0.001 |
Diabetes, n (%) | 1703 (13.8) | 248 (6.0) | 490 (11.9) | 965 (23.7) | < 0.001 |
Hyperlipidemia, n (%) | 3455 (28.0) | 726 (17.6) | 1102 (26.7) | 1627 (39.9) | < 0.001 |
Current smoking, n (%) | 3229 (28.5) | 747 (19.9) | 1086 (28.6) | 1396 (37.0) | < 0.001 |
Total cholesterol, mg/dL | 197.5 ± 34.0 | 188.2 ± 31.7 | 197.5 ± 32.9 | 206.8 ± 34.9 | < 0.001 |
Triglyceride, mg/dL | 141.7 ± 89.4 | 73.2 ± 17.3 | 122.6 ± 22.2 | 230.0 ± 102.2 | < 0.001 |
HDL-C, mg/dL | 53.3 ± 16.0 | 60.2 ± 16.4 | 52.7 ± 14.9 | 47.1 ± 13.6 | < 0.001 |
LDL-C, mg/dL | 122.0 ± 31.7 | 114.2 ± 29.5 | 125.5 ± 31.1 | 126.2 ± 33.1 | < 0.001 |
Glucose, mg/dL | 97.8 ± 20.3 | 89.5 ± 10.7 | 96.4 ± 14.0 | 107.6 ± 27.7 | < 0.001 |
HbA1C,  % | 5.7 ± 0.7 | 5.5 ± 0.5 | 5.6 ± 0.6 | 5.9 ± 1.0 | < 0.001 |
Creatinine, mg/dL | 0.95 ± 0.17 | 0.92 ± 0.18 | 0.96 ± 0.16 | 0.97 ± 0.17 | < 0.001 |